You are here

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Last updated on July 11, 2019

FOR MORE INFORMATION
Study Location
Alliance Dermatology and Mohs Center
Phoenix, Arizona, 85032 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female between the ages of 18 and 75 years.

- Participants with a diagnosis of plaque psoriasis (psoriasis vulgaris) for at least 6
months.

- Have a PASI score of 12 or greater AND a Physician Global Assessment score of 3
(moderate) or 4 (severe).

- Have plaque-type psoriasis covering at least 10 % of total body surface area (BSA).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Have non-plaque forms of psoriasis.

- Drug-induced psoriasis.

- Current active infection.

- Infected with Mycobacterium tuberculosis (TB).

- Have any history of malignancies.

- Require treatment with prohibited concomitant medications(s).

- Positive for hepatitis B or C, or human immunodeficiency virus (HIV).

NCT03895372
Pfizer
Recruiting
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now